Skip to main content
Back to FDA REMS restrictions limit mifepristone despite Dobbs ruling
55419d8d-7930-4bbc-967a-71c081af039b
Easy
true false

The new rule reversed a 2023 policy that allowed certified pharmacies to mail mifepristone directly to patients.

Explanation

Rolling back the mail option proves how quickly administrative policy can swing with new leadership.

This question is part of FDA REMS restrictions limit mifepristone despite Dobbs ruling. 5 more questions available.

The new rule reversed a 2023 policy that allowed certified pharmacies to mail mifepristone directly to patients. - FDA REMS restrictions limit mifepristone despite Dobbs ruling | Principle Civics